|Day Low/High||8.66 / 8.90|
|52 Wk Low/High||2.56 / 19.99|
If you control your risk, then the returns will come.
Biotechnology stocks can be risky but it's helpful to track them over time.
Breadth is running very poor -- at more than 2 to 1 negative.
Slew of news hasn't created much action.
I'm even staying away from the appealing stocks.
Because every stock has a unique personality that requires its own strategy.
Investors in Aratana Therapeutics, Inc saw new options begin trading this week, for the May 2017 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Instead of celebration of good gains, there is grumbling about not keeping pace with the indices.
It's challenging to put cash to work but I'll keep digging.
Meanwhile, I continue to hold long-term favorites like Energy Recovery, TPI Composites and Aratana.
Despite the unsettled market, there are still some interesting picks out there.
I may have to use an index play to get more money to work.
If the market closes weak today, it will be marked with an exclamation point.
Cramer is sticking with International Paper and likes Advanced Micro Devices.
This is not the time to sell in a panic, Cramer says.
Typically a move like this will bring in momentum buyers that chase breakouts.
Plus, September is usually the worst month of the year.
Cramer says McCormick is up too much and he's not chasing Clayton Williams Energy.
There are too many companies in just about every sector of this market, Cramer says.
Here are four stocks to watch with strong technical momentum.
The action in the indices is poor; I'll manage positions closely.
The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 706,816 share decrease in total short interest for Aratana Therapeutics, Inc , to 4,048,011, a decrease of 14.87% since 07/29/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Investors in Aratana Therapeutics, Inc saw new options begin trading today, for the October 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PETX options chain for the new October 21st contracts and identified one put and one call contract of particular interest.